Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-27

FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved BluePoint Laboratories' ziprasidone hydrochloride as a generic from an Abbreviated New Drug Application. The approval covers the same indications a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIPRASIDONE HYDROCHLORIDE (Ziprasidone hydrochloride)

Snippet

ORIG AP for ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE HYDROCHLORIDE)